Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas (original) (raw)
Steinman RM . Dendritic cells. In: Paul WE (ed) . Fundamental Immunology Lippincott-Raven: Philadelphia 1999 547–573 Google Scholar
Banchereau J, Steinman RM . Dendritic cells and the control of immunity Nature 1998 392: 245–252 ArticleCASPubMed Google Scholar
Hart DNJ . Dendritic cells: unique leukocyte populations which control the primary immune response Blood 1997 90: 3245–3287 CASPubMed Google Scholar
Inaba K et al. Generation of large numbers of dendritic cells from bone marrow cultures supplemented with granulocyte–macrophage colony-stimulating factor J Exp Med 1992 176: 1693–1702 ArticleCASPubMed Google Scholar
Mayordomo JI et al. Bone marrow derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity Nature Med 1995 1: 1297–1302 ArticleCASPubMed Google Scholar
Sallusto F, Lanzavecchia A . Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte–macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor alpha J Exp Med 1994 179: 1109–1118 ArticleCASPubMed Google Scholar
Paglia P, Chiodoni C, Rodolfo M, Colombo MP . Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivoJ Exp Med 1996 183: 317–322 ArticleCASPubMed Google Scholar
Boczkowski D, Nair SK, Snyder D, Gilboa E . Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivoJ Exp Med 1996 184: 465–472 ArticleCASPubMed Google Scholar
Specht J et al. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases J Exp Med 1997 186: 1213–1221 ArticleCASPubMedPubMed Central Google Scholar
Nair SK, Snyder D, Rouse BT, Gilboa E . Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts Int J Cancer 1997 70: 706–715 ArticleCASPubMed Google Scholar
Gong J et al. Reversal of tolerance to human MUC1 antigen in MUC1 Transgenic mice immunized with fusions of dendritic and carcinoma cells Proc Natl Acad Sci USA 1998 95: 6279–6283 ArticleCASPubMedPubMed Central Google Scholar
Gong J et al. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells Gene Therapy 1997 4: 1023–1028 ArticleCASPubMed Google Scholar
Song W et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity J Exp Med 1997 186: 1247–1256 ArticleCASPubMedPubMed Central Google Scholar
Rescigno M et al. Bacteria induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells Proc Natl Acad Sci USA 1997 95: 5229–5234 Article Google Scholar
De Smedt T et al. Regulation of dendritic cells numbers and maturation by lipopolysaccharide in vivoJ Exp Med 1996 184: 1413–1424 ArticleCASPubMed Google Scholar
Sparwasser T et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells Eur J Immunol 1998 28: 2045–2054 ArticleCASPubMed Google Scholar
Roake JA et al. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccaride, tumor necrosis factor, and interleukin-1 J Exp Med 1995 181: 2237–2247 ArticleCASPubMed Google Scholar
Caux C et al. Activation of human dendritic cells through CD40 cross-linking J Exp Med 1994 180: 1263–1272 ArticleCASPubMed Google Scholar
Zitvogel L et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines J Exp Med 1996 183: 87–97 ArticleCASPubMed Google Scholar
Tüting T et al. Autologous human monocyte derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1 biasing cytokines IL-12 and IFN-α J Immunol 1998 160: 1139–1147 PubMed Google Scholar
Zitvogel L et al. IL-12-engineered dendritic cells serve as effective tumor vaccine ajuvants in vivoAnn NY Acad Sci 1996 795: 284–293 ArticleCASPubMed Google Scholar
Qian C, Bilbao R, Bruña O, Prieto J . Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes virus thymidine kinase Hepatology 1995 22: 118–123 CASPubMed Google Scholar
Dietz AB, Vuk-Pavlovic S . High efficiency adenovirus-mediated gene transfer to human dendritic cells Blood 1998 91: 392–398 CASPubMed Google Scholar
Couffinhal T et al. Histochemical staining following LacZ gene transfer understimates transfection efficiency Hum Gene Ther 1997 8: 929–934 ArticleCASPubMed Google Scholar
Arthur JF et al. A comparison of gene transfer methods in human dendritic cells Cancer Gene Ther 1997 4: 17–25 CASPubMed Google Scholar
Mazzolini G et al. Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing IL-12 Cancer Gene Ther 1999 (in press)
Zitvogel L et al. Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts J Immunol 1995 155: 1393–1403 CASPubMed Google Scholar
Huang AYC et al. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product Proc Natl Acad Sci USA 1996 93: 9730–9735 ArticleCASPubMedPubMed Central Google Scholar
Matsuno K, Ezaki T, Kudo S, Uehara Y . A life stage of particle laden rat dendritic cells in vivo: their terminal division, active phagocytosis and translocation from liver to draining lymph J Exp Med 1996 183: 1865–1878 ArticleCASPubMed Google Scholar
Celluzi C, Falo LD . Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection J Immunol 1998 160: 3081–3085 Google Scholar
Albert ML, Sauter B, Bhardwaj N . Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 1998 392: 86–89 ArticleCASPubMed Google Scholar
Albert ML et al. Immature dendritic cells phagocytose apoptotic cells via avβ5 and CD36, and crosspresent antigens to cytotoxic T lymphocytes J Exp Med 1998 188: 1359–1368 ArticleCASPubMedPubMed Central Google Scholar
Trinchieri G . Interleukin-12: a cytokine at the interface of inflammation and immunity Adv Immunol 1998 70: 83–243 ArticleCASPubMed Google Scholar
Fernandez NC et al. High frequency of specific CD8+ T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancer J Immunol 1999 162: 609–617 CASPubMed Google Scholar
Coughlin CM et al. Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis Immunity 1998 9: 25–34 ArticleCASPubMed Google Scholar
Grohman U et al. IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production Immunity 1998 9: 315–323 Article Google Scholar
Grohman U et al. Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide Crit Rev Immunol 1998 18: 87–98 Article Google Scholar
Fallarino F, Uyttenhove C, Boon T, Gajewski TF . Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12 Int J Cancer 1998 80: 324–333 Article Google Scholar
Leonard JP et al. Effects of single dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-γ production Blood 1997 90: 2541–2548 CASPubMed Google Scholar
Ludewig B et al. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue J Exp Med 1998 188: 1493–1501 ArticleCASPubMedPubMed Central Google Scholar
Cao X et al. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity J Immunol 1998 161: 6238–6244 CASPubMed Google Scholar
Melero I et al. Monoclonal antibodies against the 4–1BB T cell activation molecule eradicate established tumors Nature Med 1997 3: 682–685 ArticleCASPubMed Google Scholar
Prieto I et al. Simple strategy to induce antibodies of distinct specificity: application to the mapping of gp120 and inhibition of HIV-1 infectivity Eur J Immunol 1995 2: 877–883 Article Google Scholar